Coya Therapeutics Inc. (COYA)

7.64

0.56 (7.91%)

At close: Mar 03, 2025, 3:59 PM

7.40

-3.14%

After-hours: Mar 03, 2025, 04:00 PM EST

Coya Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20
Net Income	-7.99M	-12.24M	-4.89M	-733.2K
Depreciation & Amortization	27.36K	27.36K	16.13K	n/a
Stock-Based Compensation	872.25K	207.35K	233.22K	n/a
Other Working Capital	-4.94M	-93.45K	74K	-27.27K
Other Non-Cash Items	543.19K	4.02M	-399.68K	158.76K
Deferred Income Tax	n/a	n/a	399.68K	n/a
Change in Working Capital	-4.64M	751.84K	739.17K	77.95K
Operating Cash Flow	-11.19M	-7.24M	-3.9M	-391.27K
Capital Expenditures	n/a	n/a	-136.8K	n/a
Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	-543.19K	-525K	n/a	n/a
Investing Cash Flow	-543.19K	-525K	-136.8K	n/a
Debt Repayment	n/a	10.47M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	89.95K	-1.11M	-340.58K	9.11M
Financial Cash Flow	38.43M	9.36M	-340.58K	9.11M
Net Cash Flow	26.69M	1.59M	-4.38M	8.72M
Free Cash Flow	-11.19M	-7.24M	-4.04M	-391.27K